Concepedia

Publication | Open Access

Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study

84

Citations

8

References

2022

Year

References

YearCitations

Page 1